GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents

2014 ◽  
Vol 34 (11) ◽  
pp. 1174-1186 ◽  
Author(s):  
Jennifer M. Trujillo ◽  
Wesley Nuffer
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Receptor Agonists ◽  
Recent Developments

Abstract #295 GLP-1 Receptor Agonists and Death From Any Cause in Elderly Patients with Type 2 Diabetes Mellitus: A Post-Hoc Analysis

2018 ◽  
Vol 24 ◽  
pp. 80-81
Author(s):  
Konstantinos Toulis ◽  
Krishna Gokhale ◽  
G. Neil Thomas ◽  
Wasim Hanif ◽  
Krishnarajah Nirantharakumar ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Elderly Patients ◽  
Post Hoc Analysis ◽  
Receptor Agonists ◽  
Post Hoc

scholarly journals Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus

2019 ◽  
Vol 4 (2) ◽  
pp. 277-286 ◽  
Author(s):  
Margarita Capel ◽  
Andreea Ciudin ◽  
María Mareque ◽  
Raquel María Rodríguez-Rincón ◽  
Susana Simón ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Receptor Agonists ◽  
Effectiveness Analysis

scholarly journals Weight loss variability with SGLT2 inhibitors and GLP‐1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities

2019 ◽  
Vol 20 (6) ◽  
pp. 816-828 ◽  
Author(s):  
Emily Brown ◽  
John P.H. Wilding ◽  
Thomas M. Barber ◽  
Uazman Alam ◽  
Daniel J. Cuthbertson
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Weight Loss ◽  
Type 2 Diabetes Mellitus ◽  
Sglt2 Inhibitors ◽  
Receptor Agonists
Sign in / Sign up

Export Citation Format

Share Document